Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

ASTRAZENECA PHARMA INDIA LTD.

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC

BSE9096.4534.2 (+0.38 %)

PREV CLOSE ( ) 9062.25

OPEN PRICE ( ) 9093.95

BID PRICE (QTY) 9096.55 (3)

OFFER PRICE (QTY) 9119.45 (12)

VOLUME 27

TODAY'S LOW / HIGH ( )9066.70 9130.95

52 WK LOW / HIGH ( )6301 10653.05

NSE9101.5010 (+0.11 %)

PREV CLOSE( ) 9091.50

OPEN PRICE ( ) 9140.00

BID PRICE (QTY) 9102.50 (2)

OFFER PRICE (QTY) 9112.50 (1)

VOLUME 1311

TODAY'S LOW / HIGH( ) 9050.00 9140.00

52 WK LOW / HIGH ( )6312.75 10691

Quarters

Select year

( in Million)

Particulars

Sep 2025

Jun 2025

Mar 2025

Dec 2024

Audited / UnAudited

UnAudited

Net Sales

5590.9

5263.1

4804.8

4402.9

Total Expenditure

4839.1

4452

3941.1

3633

PBIDT (Excl OI)

751.79

811.1

863.7

769.9

Other Income

61.7

112.4

161.5

79.8

Operating Profit

813.5

923.5

1025.2

849.7

Interest

6.7

7.2

6.8

3.3

Exceptional Items

-52.9

-3.6

-56.8

-335.5

PBDT

753.9

912.7

961.6

510.9

Depreciation

25.7

165.7

176.9

90.7

Profit Before Tax

728.2

747

784.7

420.2

Tax

186

188.7

202.2

111.7

Provisions and contingencies

Profit After Tax

542.2

558.3

582.5

308.5

Extraordinary Items

Prior Period Expenses

Other Adjustments

0.00

Net Profit

542.2

558.3

582.5

308.5

Equity Capital

Face Value (IN RS)

Reserves

Calculated EPS

21.68

22.33

23.3

12.34

Calculated EPS (Annualised)

86.75

89.32

93.20

49.36

No of Public Share Holdings

6250000

% of Public Share Holdings

PBIDTM% (Excl OI)

13.44

15.41

17.97

17.48

PBIDTM%

14.55

17.54

21.33

19.29

PBDTM%

13.48

17.34

20.01

11.60

PBTM%

13.02

14.19

16.33

9.54

PATM%

9.69

10.60

12.12

7.00

Notes

Risk Disclosures on Derivatives

Quarterly Results

ASTRAZENECA PHARMA INDIA LTD.